Home AstraZeneca

AstraZeneca

In operation
IPO
Biopharmaceutical Manufacturer
Basic
Enterprise Profile
LinkedIn

Basic Information

AstraZeneca is a global innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription drugs that have a significant impact on healthcare. AstraZeneca focuses on discovering new medicines that improve the health and quality of life for patients worldwide, such as reducing side effects or adopting better treatment methods. They also concentrate on achieving the best outcomes from every drug they manufacture by exploring all possible methods for use or improvement. We focus on the discovery, development, and commercialization of prescription drugs in the fields of oncology and biopharmaceuticals, including cardiovascular, renal, metabolic, respiratory, and immunology.
AstraZeneca PLC
Cambridge,England,United Kingdom
more than 500 people
April 06, 1999
--

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Manufacture of Biological Pharmaceutical Products Gene Therapy
Technology
Gene Technology Targeted Technology Immunological Techniques Cell Technology Protein Technology
Concept
Department of Rheumatology and Immunology Cardiovascular Disease Respiratory Diseases Digestive System Diseases Therapeutic Products Ovarian Cancer Breast Cancer # Liver Cancer Lung Cancer Cervical Cancer Gastric Cancer Lymphoma Colorectal Cancer Prostate Cancer Leukemia Lupus Erythematosus Depression
Application Scenarios
Chemical Drug Innovative Drugs Monoclonal Antibody Bispecific Antibody ADC (Antibody-Drug Conjugate) Nucleic Acid Drugs Cell and Gene Therapy Small Nucleic Acid Drugs AI+Pharmaceuticals